UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

International journal of infectious diseases, 2021-02, Vol.103, p.62-71

2021

Volltextzugriff (PDF)

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al

International journal of infectious diseases, 2021-04, Vol.105, p.686-687

2021

Volltextzugriff (PDF)

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD

Lung India, 2022-11, Vol.39 (6), p.517-524

2022

Volltextzugriff (PDF)

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

ERJ open research, 2021-07, Vol.7 (3), p.255

2021

Volltextzugriff (PDF)

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers

Clinical therapeutics, 2010-03, Vol.32 (3), p.588-596

2010

Volltextzugriff (PDF)

Surfactant Free Synthesis of Magnesium Oxide Nanotubes by Simple Chemical Co-Precipitation Method

International journal of innovative technology and exploring engineering, 2020-02, Vol.9 (4), p.2504-2506

2020

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function

Pain (Amsterdam), 2022-06, Vol.163 (6), p.e738-e747

2022

Volltextzugriff (PDF)

In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC–MS/MS analysis

Journal of pharmaceutical and biomedical analysis, 2019-02, Vol.164, p.698-705

2019

Volltextzugriff (PDF)

Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)

Journal of the Association of Physicians of India, 2024-01, Vol.72 (1), p.32

2024

Volltextzugriff (PDF)

Effect of Solvent Medium on Optical and Structural Properties of ZnO–SnO 2 Nanocomposite

Advanced science, engineering and medicine, 2018-07, Vol.10 (7), p.745-749

2018

Volltextzugriff (PDF)

800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

Drugs (New York, N.Y.), 2020-04, Vol.80 (6), p.587-600

2020

Volltextzugriff (PDF)

A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers

Clinical therapeutics, 2007-12, Vol.29 (12), p.2677-2684

2007

Volltextzugriff (PDF)

Abstract 165: Study of lobeglitazone for evaluation of safety and efficacy with active comparator pioglitazone in Indian T2DM patients: A randomized phase III trial (sensitize India)

Indian journal of endocrinology and metabolism, 2022-12, Vol.26 (8), p.70-70

2022

Volltextzugriff (PDF)

SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial

The Lancet regional health. Southeast Asia, 2022-08, Vol.3, p.100036-100036, Article 100036

2022

Volltextzugriff (PDF)

An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.349-357

2020

Volltextzugriff (PDF)

Determination of Interchangeability of Different Brands of Diclofenac Sodium Sustained Release Tablets in Healthy Subjects Using Pharmacokinetic End Points

Letters in drug design & discovery, 2009-12, Vol.6 (8), p.629-636

2009

Volltextzugriff (PDF)

Correction to “SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial”

The Lancet regional health. Southeast Asia, 2022-12, Vol.7, p.100110-100110, Article 100110

2022

Volltextzugriff (PDF)

Genotype–phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region

European journal of drug metabolism and pharmacokinetics, 2013-12, Vol.38 (4), p.275-282

2013

Volltextzugriff (PDF)

Effect of annealing temperature on optical properties and dye absorbance capacity of ZnO-CdS nanocomposite

Advanced Materials Proceedings, 2021-12, Vol.2 (2), p.103-106

2021

Volltextzugriff (PDF)

Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory

SpringerPlus, 2012-10, Vol.1 (1), p.34-34, Article 34

2012

Volltextzugriff (PDF)

Comparative Evaluation of US Food and Drug Administration and Pharmacologically Guided Approaches to Determine the Maximum Recommended Starting Dose for First-in-Human Clinical Trials in Adult Healthy Men

Journal of clinical pharmacology, 2011-12, Vol.51 (12), p.1655-1664

2011

Volltextzugriff (PDF)

The Effects of Rosuvastatin on the Serum Cortisol, Serum Lipid, and Serum Mevalonic Acid Levels in the Healthy Indian Male Population

AAPS PharmSciTech, 2010-03, Vol.11 (1), p.425-432

2010

Volltextzugriff (PDF)

MAGNIFICATION, ULTRASONICS AND BIOCERAMICS - THE IDEAL TRIO FOR FILE RETRIEVAL: A CASE REPORT

BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY, 2023-01, p.9-13

2023

Volltextzugriff (PDF)

Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects

European journal of clinical pharmacology, 2005-10, Vol.61 (9), p.621-625

2005

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(104)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(130)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(44)
Humans
(22)
Physical Sciences
(16)
India
(15)
Male
(14)
Physics
(14)
Technology
(14)
Female
(13)
Materials Science
(13)
Pharmacology & Pharmacy
(13)
Materials Science, Multidisciplinary
(12)
Physics, Applied
(11)
Adult
(10)
Public, Environmental & Occupational Health
(9)
Biological And Medical Sciences
(7)
Biomedical And Life Sciences
(7)
Covid-19
(7)
Medical Sciences
(7)
Pharmacology/toxicology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers

Surfactant Free Synthesis of Magnesium Oxide Nanotubes by Simple Chemical Co-Precipitation Method

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function

In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC–MS/MS analysis

Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)

Effect of Solvent Medium on Optical and Structural Properties of ZnO–SnO 2 Nanocomposite

800-P: Phase 3 Results of Fixed-Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers

Abstract 165: Study of lobeglitazone for evaluation of safety and efficacy with active comparator pioglitazone in Indian T2DM patients: A randomized phase III trial (sensitize India)

SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial

An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions

Determination of Interchangeability of Different Brands of Diclofenac Sodium Sustained Release Tablets in Healthy Subjects Using Pharmacokinetic End Points

Correction to “SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial”

Genotype–phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region

Effect of annealing temperature on optical properties and dye absorbance capacity of ZnO-CdS nanocomposite

Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory

Comparative Evaluation of US Food and Drug Administration and Pharmacologically Guided Approaches to Determine the Maximum Recommended Starting Dose for First-in-Human Clinical Trials in Adult Healthy Men

The Effects of Rosuvastatin on the Serum Cortisol, Serum Lipid, and Serum Mevalonic Acid Levels in the Healthy Indian Male Population

MAGNIFICATION, ULTRASONICS AND BIOCERAMICS - THE IDEAL TRIO FOR FILE RETRIEVAL: A CASE REPORT

Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects

Suchergebnisse filtern